Abstract
Objectives:
To propose objective ratios using anthropometry and dual-energy X-ray absorptiometry (DXA) and to suggest cutoff points for them in order to classify lipodystrophy in male patients.
Methods:
It is a cross-sectional study. DXA was applied and anthropometric measurements were performed in 100 men on highly active antiretroviral therapy. Receiver operating characteristic curves were used to propose cutoffs. Individuals were divided in without (lipo−) or with (lipo+) lipodystrophy and their metabolic parameters were compared.
Results:
The following ratios were proposed: fat mass ratio by DXA (FMR), waist thigh ratio (WTR), waist calf ratio (WCR), and arm to trunk ratio (ATR). The best cutoffs observed for FMR, WTR and ATR were 1.26, 1.74 and 2.08, respectively. Using the proposed cutoff for FMR, we observed worse metabolic profile, with increased tryglicerides, fasting serum glucose and more hypercholesterolemia in the lipo+ group. WTR and ATR showed a significant correlation with FMR.
Conclusions:
Anthropometric ratios (WTR/ATR) and FMR can be used to aid the diagnosis of lipodystrophy in order to contribute to a more accurate and earlier diagnosis permitting intervention and even preventing metabolic disturbances.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Marins JRP, Jamal LF, Chen SY, Barros MB, Hudes ES, Barbosa AA et al. Dramatic improvement in survival among adult Brazilian AIDS patients. AIDS 2003; 17: 1675–1682.
Boskurt B . Cardiovascular toxicity with highly active antiretroviral therapy: review of clinical study. Cardiovasc Toxicol 2004; 4: 243–260.
Brown T, Wang Z, Chu H, Palela FJ, Kingsley L, Witt MD et al. Longitudinal anthropometric changes in HIV-infected and HIV-uninfected men. J Acquir Immune Defic Syndr 2006; 43: 356–362.
Torriani M, Thomas BJ, Barlow RB, Librizzi J, Dola NS, Grinspoon S . Increased intramyocellular lipid accumulation in HIV infected women with fat redistribution. Journal of applied physiology 2006; 100: 609–4.
Baril JG, Junod G, Leblanc R, Dion H, Therrien R, Laplant F et al. HIV – associated lipodystrophy syndrome: a review of clinical aspects. J Infect Dis Med Microbiol 2005; 16: 233–243.
Tershakovec A, Frank I, Rader D . HIV-related lipodystrophy and related factors. Atherosclerosis 2004; 174: 1–10.
Bonnet E, Delpierre C, Sommet A, Mario-Latard F, Hervé R, Aquilina C et al. Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men. J Clin Densitom 2005; 8: 287–292.
Freitas P, Santos AC, Carvalho D, Pereira J, Marques R, Martinez E et al. Fat mass ratio: an objective tool to define lipodystrophy in HIV-infected patients under antiretroviral. therapy. J Clin Densitom 2010; 13: 197–203.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III – ATP III). JAMA 2001; 285: 2486–2497.
Sutinen J, Yki-Jarvinen H . Increased resting energy expenditure, fat oxidation, and food intake in patients with highly active antiretroviral therapy-associated lipodystrophy. Am J Physiol End Met 2007; 292: E687–E692.
Lohman TG, Roche AF, Martorell R Anthropometric standardization reference manual. Human Kinetics Books: Champaign, 1988.
Lohman TG, Roche AF, Martorell R Anthropometric standardization reference manual: a bridged edition. Human Kinetics Books: Champaign, 1991, p 90.
Bacchetti P, Gripshover B, Grunfeld C, Heymsfield S, McCreath H, Osmond D et al. From the Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM). Fat distribution in men with HIV Infection. J Acquir Immune Defic Syndr 2005; 40: 121e131.
Bedimo RJ . Body-Fat Abnormalities in Patients With HIV: Progress and Challenges. J Int Assoc Physicians AIDS Care 2008; 7: 292–305.
Kosmiski L, Kuritzkes D, Hamilton J, Sharp T, Lichtenstien K, Hill J et al. Fat distribution is altered in HIV-infected men without clinical evidence of the HIV lipodystrophy syndrome. HIV Med 2003; 4: 235–240.
Milinkovic A, Martinez E . Current perspectives on HIV-associated lipodystrophy syndrome. J Antimicrob Chemother 2005; 56: 6–9.
Carr A, Emery S, Law MG, Puls R, Lundgren JD, Powderly W . An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. HIV Lipodystrophy Case Definition Study Group. Lancet 2003; 361: 726–735.
Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998; 12: 51–58.
Massip P, Marchou B, Bonnet E, Cuzin L, Montastruc JL . Lipodystrophy with protease inhibitors in HIV patients. Therapie 1997; 52: 615.
Viraben R, Aquilina C . Indinavir-associated lipodystrophy. AIDS 1998; 12: 37–39.
Beraldo RA, Vassimon HS, Jordão J. AA, Albuquerque FJ, Machado AM, Foss-Freitas MC et al. Anthropometry and bioelectrical impedance analysis compared to dual-photon absorptiometry for the assessment of body composition of hiv-seropositive patients. Rev Chil Nutr 2011; 38: 404–413.
Weber RV, Buckley MC, Fried SK, Kral JG . Subcutaneous lipectomy causes a metabolic syndrome in hamsters. Am J Physiol Regul Integr Comp Physiol 2000; 279: 936–943.
Hadigan C, Meigs JB, Corcoran C, Rietschel P, Piecuch S, Basgoz N et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis 2001; 32: 130–139.
Barroso SG, Abreu VG, Francischetti EA . A Participação do Tecido Adiposo Visceral na Gênese da Hipertensão e Doença Cardiovascular Aterogênica. Um Conceito Emergente. Arq Bras Cardiol 2002; 78: 618–630.
Acknowledgements
We would like to thank the Infectious Disease Ambulatory division of the Ribeirão Preto Medical School, University of São Paulo, Brazil. We would like to acknowledge Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) for partially supporting this research.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Beraldo, R., Vassimon, H., Aragon, D. et al. Proposed ratios and cutoffs for the assessment of lipodystrophy in HIV-seropositive individuals. Eur J Clin Nutr 69, 274–278 (2015). https://doi.org/10.1038/ejcn.2014.149
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2014.149
This article is cited by
-
Effect of 1-year oral cholecalciferol on a metabolic profile and blood pressure in poor-controlled type 2 diabetes mellitus: an open-label randomized controlled pilot study
Journal of Endocrinological Investigation (2021)
-
HIV and antiretroviral therapy-related fat alterations
Nature Reviews Disease Primers (2020)
-
Association between lipodystrophy and length of exposure to ARTs in adult HIV-1 infected patients in Montreal
BMC Infectious Diseases (2019)
-
Endoplasmic reticulum stress activation in adipose tissue induces metabolic syndrome in individuals with familial partial lipodystrophy of the Dunnigan type
Diabetology & Metabolic Syndrome (2018)
-
Lipodystrophy diagnosis in people living with HIV/AIDS: prediction and validation of sex-specific anthropometric models
BMC Public Health (2018)